Fenofibrate-str-1 (Fenofibrate Str 1)
Fenofibrate Tablet
Product Images NDC 33342-340
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 33342-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
226 (Fenofibrate Tablets 145mg 30s)
This is a description of MacLeod's Fenofibrate tablets, each containing 145 mg of the active ingredient. The tablets are film-coated and should be kept in a tightly closed container at room temperature to protect them from moisture. The manufacturer is Macleods Pharma USA, Inc., and the usual dosage instructions can be found in the package insert. These tablets should be stored at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The tablets should not be accepted if the seal over the bottle opening is broken or missing. The manufacturing site is Macleods Pharmaceuticals Ltd. in Badd, Himachal Pradesh, India.*
889 (Fenofibrate Tablets 145mg 500s)
Each film-coated tablet contains Fenofibrate, USP 145 mg. The tablets are dispensed in a tightly closed container and should be kept out of the reach of children. The usual dosage information can be found in the package insert. Store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). If the seal over the bottle opening is broken or missing, do not accept the product. These tablets are manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. This batch includes 500 Tablets.*
009 (Fenofibrate Tablets 145mg 90s)
This is information about a medication containing Fenofibrate, USP 145 mg in film-coated tablets. The tablets should be stored in a tightly sealed container at room temperature and protected from moisture. The usual dosage instructions can be found in the package insert. The tablets are manufactured for Macleods Pharma USA, Inc. and have an area of 43 x 19 mm. The product should not be used if the seal over the bottle opening is broken or missing.*
898 (Fenofibrate Tablets 48mg 30s)
808 (Fenofibrate Tablets 48mg 500s)
This is the description obtained from the text:
This text provides the details for Fenofibrate Tablets, USP containing 500 tablets with each film-coated tablet containing 48 mg of Fenofibrate, USP. The usual dosage information can be found in the package insert. It advises to store the tablets at 20°C to 25°C, protect from moisture, and keep out of reach of children. Manufactured by Macleods Pharma USA and Mackeods Pharmaceuticals in India, the product should not be used if the seal over the bottle opening is broken or missing.*
990 (Fenofibrate Tablets 48mg 90s)
This text provides information about Fenofibrate tablets, USP, with a strength of 48 mg per film-coated tablet. The usual dosage instructions are available in the package insert. The tablets should be kept in a tightly closed container, away from children, and protected from moisture. The storage conditions should be maintained between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It also mentions not to use the product if the seal over the bottle opening is broken or missing. The product is manufactured by Macleods Pharma USA, Inc., for Macleods Pharmaceuticals Ltd. in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
